Recruiting
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
ClinicalTrials.gov IDNCT05704283
PhaseEARLY_PHASE1
Enrollment55
SponsorMayo Clinic
Age18 Years
SexFEMALE
Conditions studied
Breast Carcinoma
About this study
This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
Interventions
- Device: Ultrasound Imaging — Undergo 3D-US
Primary outcomes
- Lymph node diagnosis by radiologist (benign or malignant) (Aim 2) (Up to 2 years)
Eligibility information
Inclusion Criteria:
* Patients with lymph node biopsy or lymph node clip placement as per routine clinical care.
* Age of 18 or older.
Exclusion Criteria:
* Vulnerable subjects such as prisoners and adults lacking capacity to consent.
Study locations
- Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.